Elevance Health, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Elevance Health's 2025 annual report shows revenue growth driven by acquisitions and Medicare Advantage, but net income and cash flow declined due to higher medical costs and a significant legal settlement.
NYSE
Elevance Health showcases a resilient performance in 2024, marked by revenue growth and strategic acquisitions, while addressing challenges from Medicaid redeterminations and adjustments in Medicare Advantage Star Ratings.
NYSE
Elevance Health's 2023 annual report highlights a year of strategic realignment, solid membership, and revenue growth, despite challenges in the Medicaid sector.